Treating pain without opioids has become possible for many patients through novel drugs approved by a regulatory process called 505(b)(2). Now, access to these treatments is in jeopardy.
As a pain management specialist, I can see how the COVID-19 pandemic has disrupted patients’ access to treatments like targeted injections or physical therapy.
Even as COVID-19 dominates headlines, the opioid crisis continues.
As outlined in The Journals of Gerontology, researchers found that opioid use is “significantly” linked to an increased risk of falls and fall injuries among seniors.